The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Director Dealing

22 Dec 2015 15:08

RNS Number : 9133J
FastForward Innovations Limited
22 December 2015
 

For immediate release

22 December 2015

FastForward Innovations Limited

("FastForward" or the "Company")

Placing

Director Dealing

Further to the announcement by FastForward Innovations Limited (AIM: FFWD) on 21 December 2015, the Company is pleased to announce that it has today agreed to place 39,668,200 new Ordinary Shares of 1p each (the "Placing Shares") at a price of 8p per Placing Share with a number of new investors thereby raising US$4,830,000 (£3,173,456 at an exchange rate of £1:US$1.522, being the rate on the date the Company determined the terms of the placing) before expenses (the "Placing"). The proceeds of the Placing will be used to assist the Company in making investments in accordance with its investing policy and for general working capital purposes.

In accordance with the terms of subscription letters signed by investors, payment for the Placing Shares is due by 5 January 2016. Subject to payment, the Placing Shares (which will rank pari passu with the existing Ordinary Shares) will be issued and allotted on 8 January 2016, with application for the Placing Shares to be admitted to trading on AIM ("Admission") and dealings commencing at 8.00 a.m. on 11 January 2016. The Company expects that the enlarged issued share capital following the issue of the Placing Shares and also the consideration shares to be issued on completion of the Vemo acquisition (as announced on 21 December 2015) will be 96,681,544 Ordinary Shares (the "Enlarged Issued Share Capital").

Related Party Transaction

Mr Stephen Dattels, Mr Jim Mellon and Mr Ian Burns (who are each Directors of the Company) have each participated in the Placing. In addition, the Company announced on 21 December 2015 that, subject to regulatory approvals being received, it was proposed Mr Lorne Abony be appointed as a director of the Company. The participation of the Directors, and the proposed director Mr Abony, is as set out below:

Name

Subscription

Placing Shares

Total Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Stephen Dattels1

US$590,000

4,845,598

12,870,067

13.31%

Jim Mellon2

US$150,000

1,231,932

9,256,401

9.57%

Ian Burns3

US$15,000

123,193

1,374,024

1.42%

Lorne Abony

US$2,000,000

16,425,756

20,754,181

21.47%

1 Mr Dattels' interest in shares is held by Regent Mercantile Holdings Limited, a company owned by a trust under which Mr Dattels is a discretionary beneficiary.

2 Mr Mellon's interest in shares is held by Galloway Limited, a company owned by a trust of which Mr James Mellon is a life tenant.

3 Mr Burns' interest in shares is held by Smoke Rise Holdings Limited, a company of which he is the sole shareholder.

The Directors are related parties for the purposes of the AIM Rules and it has also been deemed that Mr Abony, should also be treated as a related party for the purposes of the AIM Rules given his proposed appointment to the Board. The participation of the three Directors and Mr Abony in the Placing constitutes a Related Party Transaction under Rule 13 of the AIM Rules for Companies.

Accordingly, Mr Bryan Smith, the independent director of the Company, confirms that, having consulted with the Company's Nominated Adviser, the terms of the Placing are fair and reasonable insofar as the Company's shareholders are concerned. In particular Mr Smith notes that the Directors and Mr Abony have participated on the same terms as all other investors.

The Investors

In addition to Mr Abony, Mr Mellon and Mr Dattels, following the issue of the Placing Shares the following shareholders will be interested in more than 3 per cent. of the Enlarged Issued Share Capital :

Name

Number of Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital

Mr Norbert Teufelberger

4,106,439

4.25%

Russell Geyser

3,285,151

3.40%

Wendy Polland

3,285,151

3.40%

Issued Shares

Following Admission of the Placing Shares and the consideration shares to be issued on completion of the Vemo acquisition (as announced on 21 December 2015), the Company's enlarged issued share capital will consist of 96,681,544 Ordinary Shares with voting rights. This number may be used by shareholders, following the Placing, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please visit www.kualainnovations.com or contact:

James Biddle/ Michael Cornish (Nomad)

Beaumont Cornish LimitedTel: +44 207 628 3396

 

Peterhouse Corporate Finance Limited

Guy Miller/ Lucy Williams

Tel: +44 (0) 207 469 0930

Elysium Fund Management Limited

PO Box 650

1st Floor

Royal Chambers

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: elysium@elysiumfundman.com

 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Limited. There can be no assurance that such statements will prove to be accurate, achievable or recognisable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMMZZKZDGKZM
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.